Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;95(10):3425-3432.
doi: 10.1007/s00204-021-03124-x. Epub 2021 Jul 24.

Low-dose radiation therapy (LDRT) for COVID-19 and its deadlier variants

Affiliations

Low-dose radiation therapy (LDRT) for COVID-19 and its deadlier variants

Rachna Kapoor et al. Arch Toxicol. 2021 Oct.

Abstract

Coronavirus variants are gaining strongholds throughout the globe. Despite early signals that SARS-CoV-2 coronavirus case numbers are easing up in the United States and during the middle of a (not so easy) vaccination roll out, the country has passed a grim landmark of 600,000 deaths. We contend that these numbers would have been much lower if the medical community undertook serious investigations into the potential of low doses of radiation (LDRT) as a mainstream treatment modality for COVID-19 pneumonia. LDRT has been posited to manifest anti-infectious and anti-inflammatory properties at doses of 0.3-1.0 Gy via the activation of the Nrf-2 pathway. Although some researchers are conducting well-designed clinical trials on the potential of LDRT, the deep-rooted, blind, and flawed acceptance of the Linear No-Threshold (LNT) model for ionizing radiation has led to sidelining of this promising therapy and thus unimaginable numbers of deaths in the United States.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
LDRT induced Nrf2 activation and its effect on SARS-CoV-2 (including variants) induced pneumonitis (adapted from Calabrese et al. 2021)

References

    1. Ameri A, Ameri P, Rahnama N, Mokhtari M, Sedaghat M, Hadavand F, Bozorgmehr R, Haghighi M, Taghizadeh-Hesary F. Low-dose whole-lung irradiation for COVID-19 pneumonia: final results of a pilot study. Int J Radiat Oncol Biol Phys. 2021;109(4):859–866. doi: 10.1016/j.ijrobp.2020.11.065. - DOI - PMC - PubMed
    1. Arenas M, Algara M, De Febrer G, Rubio C, et al. Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial) Strahlenther Onkol. 2021;6:1–11. doi: 10.1007/s00066-021-01803-3. - DOI - PMC - PubMed
    1. Bevelacqua JJ, Welsh JS, Mortazavi S. Comments on: "Low dose radiation therapy for severe COVID-19 pneumonia: a randomized double-blind study". Int J Radiat Oncol Biol Phys. 2021;S0360–3016(21):00445–454. doi: 10.1016/j.ijrobp.2021.04.025. - DOI
    1. Calabrese EJ. LNT and cancer risk assessment: Its flawed foundations part 1: radiation and leukemia: where LNT began. Environ Res. 2021;18(197):111025. doi: 10.1016/j.envres.2021.111025. - DOI - PubMed
    1. Calabrese EJ. LNT and cancer risk assessment: Its flawed foundations part 2: How unsound LNT science became accepted. Environ Res. 2021;29(197):111041. doi: 10.1016/j.envres.2021.111041. - DOI - PubMed

Publication types

Substances

LinkOut - more resources